The Asthma, COPD & Allergic Rhinitis Market Outlook to eBook Free

0/5 No votes

Report this app

Description


The combined market for asthma, COPD and allergic rhinitis drugs is expected to decline slightly to $42.0bn between 2010 and 2016. Patent expiries combined with a tough regulatory environment are the key market resistors.

πŸ“ Download Mirror 1 πŸ“ Download Mirror 2 πŸ“ EXTERNAL MIRROR
πŸ“ Download Mirror 1 πŸ“ Download Mirror 2 πŸ“ EXTERNAL MIRROR

Versions

Version Size Requirements Date

Leave a Reply